DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
N•••••• P••••••••• L••
P•••••••••, Biotechnology and Life Sciencesgroup grade Aon a schedule nowsponsor unattributed
Also written as: Biotechnology & Life Sciences; LL; P•••••••••
Principal held
at least $17.2M
sum of BDC pieces, a lower bound
Fair value
$16.6M
98c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
4
3 on the latest quarter
Facilities
2
2 equity pieces beside them
Next maturity
Dec 30, 2027
$17.2M inside 24 months
On the tape since
Sep 30, 2023
latest Jun 30, 2026
Events
3
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $17.2M | 98c | SOFR+920 bp | Dec 31, 2027 | 3 |
| other lien unstated exited Sep 30, 2024 | at least $20.9M | 99c | S+1100 bp PIK 20.00% | Sep 11, 2026 | 1 |
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| C••••••• C•••••• B••• I••• | equity equity Investment T••• C••••• S•••• | n/a | n/a | |
| C••••••• C•••••• B••• I••• | term loan first lien Investment T••• U••••••••• F•••• L••• - L••• Out T••• L••• I••••••• T••• S + 920 I••••••• | $7.1M | $6.7M 95c | SOFR+920 bp |
| C••••••• P•••••• C••••• I••••• C••• | warrants equity Investment T••• C••••• S•••• W•••••• | n/a | n/a | |
| C••••••• P•••••• C••••• I••••• C••• | term loan first lien Investment T••• U••••••••• F•••• L••• - L••• Out T••• L••• I••••••• T••• S + 920 I••••••• | $2.4M | $2.2M 95c | SOFR+920 bp |
| F•••• E•••• P•••••• C••••• F••• | term loan first lien F•••• L••• D••• R•••••••• R••• and S••••• S + 4.00% I••••••• R••• F•••• 3.25% I••••••• R•• | $1.8M | $1.8M 101c | SOFR+400 bp |
| F•••• E•••• P•••••• C••••• F••• | term loan first lien F•••• L••• D••• R•••••••• R••• and S••••• S + 9.20% I••••••• R••• F•••• 3.25% I••••••• R•• | $6.0M | $6.0M 100c | SOFR+920 bp |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 3 | $17.2M | $16.6M | 98c | 0 |
| Mar 31, 2026 | 3 | $17.2M | $16.8M | 99c | 0 |
| Dec 31, 2025 | 3 | $18.0M | $18.0M | 101c | 0 |
| Sep 30, 2025 | 3 | $18.3M | $18.3M | 101c | 0 |
| Jun 30, 2025 | 3 | $18.3M | $18.3M | 101c | 0 |
| Mar 31, 2025 | 3 | $18.3M | $18.0M | 100c | 0 |
| Sep 30, 2024 | 1 | $20.9M | $20.3M | 99c | 1 |
| Jun 30, 2024 | 1 | $21.0M | $20.3M | 99c | 1 |
| Mar 31, 2024 | 1 | $19.9M | $19.4M | 100c | 0 |
| Dec 31, 2023 | 1 | $40.0M | $38.6M | 99c | 0 |
| Sep 30, 2023 | 1 | $20.0M | $19.4M | 100c | 0 |
What changed
- Maturity approachingDec 31, 2027
- Spread increasedJun 30, 2025
- Facility left every BDC scheduleSep 30, 2024
- Lender left a facilitySep 30, 2024
- PIK interest appearsJun 30, 2024
- Spread increasedJun 30, 2024
- New borrower on a BDC scheduleSep 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- N•••••• P•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 4 BDCsderived
- Industry
- P•••••••••, Biotechnology and Life Sciencesreportedas one filer wrote it